Analysis of neuroendocrine tumour metastases in the liver using contrast enhanced ultrasonography

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 5, 2007, Pages 652-662

  Mörk, Hubert ^b   Ignee, Andre ^a   Schuessler, Gudrun ^a   Ott, Michaela ^a   Dietrich, Christoph F ^a  

^a CARITAS KRANKENHAUS   (Germany)

^b Hospital of Nagold   (Germany)

Author keywords

Contrast enhanced ultrasound; Hemangioma; Metastases; Neuroendocrine tumour

Indexed keywords

ADULT; AGED; ARTICLE; B SCAN; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FATTY LIVER; FEMALE; HEPATIC ARTERY; HUMAN; LIVER BIOPSY; LIVER BLOOD FLOW; LIVER HEMANGIOMA; LIVER METASTASIS; LIVER SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NEUROENDOCRINE TUMORS; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 34247361211     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520601021765     Document Type: Article

References (33)

1. Dietrich CF, Kratzer W, Strobe D, Danse E, Fessl R, Bunk A, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006;12:1699-705.
2. Oldenburg A, Hohmann J, Foert E, Skrok J, Hoffmann CW, Frericks B, et al. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue. Ultraschall Med 2005;26:277-84.
3. Dietrich CF, Ignee A, Trojan J, Fellbaum C, Schuessler G. Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. Gut 2004;53:401-5.
4. von Herbay A, Vogt C, Haussinger D. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions. J Ultrasound Med 2002;21:1191-200.
5. Rickes S, Ocran KW, Gerstenhauer G, Neye H, Wermke W. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound. Dig Dis 2004;22:81-6.
6. Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005;78:704-7.
7. Schuessler G, Ignee A, Hirche T, Dietrich CF. [Improved detection and characterisation of liver tumors with echo-enhanced ultrasound]. Z Gastroenterol 2003;41:1167-76.
8. Dietrich CF, Chichakli M, Hirche TO, Bargon J, Leitzmann P, Wagner TO, et al. Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosis. J Ultrasound Med 2002;21:409-16.
9. van der Horst-Schrivers AN, Wymenga AN, de Vries EG. Carcinoid heart disease. N Engl J Med 2003;348:2359-61.
10. Dietrich CF, Wehrmann T, Zeuzem S, Braden B, Caspary WF, Lembcke B. [Analysis of hepatic echo patterns in chronic hepatitis C]. Ultraschall Med 1999;20:9-14.
11. Dietrich CF, Lee JH, Gottschalk R, Herrmann G, Sarrazin C, Caspary WF, et al. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. Am J Roentgenol 1998;171:437-43.
12. Rudiger T, Ott G, Ott MM, Muller-Deubert SM, Muller-Hermelink HK. Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol 1998;22:1184-91.
13. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 2004;25:458-511.
14. Makridis C, Oberg K, Juhlin C, Rastad J, Johansson H, Lorelius LE, et al. Surgical treatment of mid-gut carcinoid tumors. World J Surg 1990;14:377-83.
15. Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 2004;51 Suppl:S9-17.
16. Solcia E, Kloppel G, Sobin LH. Histological typing of endocrine tumours, 2nd edn. Heidelberg: World Health Organization; 2000.
17. Ignee A, Weiper D, Schuessler G, Teuber G, Faust D, Dietrich CF. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis. Z Gastroenterol 2005;43:289-94.
18. Albrecht T, Blomley MJ, Burns PN, Wilson S, Harvey CJ, Leen E, et al. Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study. Radiology 2003;227:361-70.
19. Shimada M, Matsumata T, Ikeda Y, Urata K, Hayashi H, Shimizu M, et al. Multiple hepatic hemangiomas with significant arterioportal venous shunting. Cancer 1994;73:304-7.
20. Oliver JH, III, Baron RL, Federle MP, Jones BC, Sheng R. Hypervascular liver metastases: do unenhanced and hepatic arterial phase CT images affect tumor detection? Radiology 1997;205:709-15.
21. Oliver JH, III, Baron RL. Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. Radiology 1996;201:1-14.
22. Taylor KJ, Ramos I, Morse SS, Fortune KL, Hammers L, Taylor CR. Focal liver masses: differential diagnosis with pulsed Doppler US. Radiology 1987;164:643-7.
23. Kim KW, Kim TK, Han JK, Kim AY, Lee HJ, Choi BI. Hepatic hemangiomas with arterioportal shunt: findings at two-phase CT. Radiology 2001;219:707-11.
24. Byun JH, Kim TK, Lee CW, Lee JK, Kim AY, Kim PN, et al. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT. Radiology 2004;232:354-60.
25. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H. Hepatic hemangioma: findings with two-phase CT. Radiology 1995;196:465-9.
26. Tanaka A, Morimoto T, Yamamori T, Moriyasu F, Yamaoka Y. Atypical liver hemangioma with shunt: long-term follow-up. J Hepatobiliary Pancreat Surg 2002;9:750-4.
27. Itai Y, Ohtomo K, Kokubo T, Yamauchi T, Tanioka H, Yoshikawa K, et al. Atypical cavernous hemangioma of the liver. Radiat Med 1988;6:135-40.
28. Jeong MG, Yu JS, Kim KW. Hepatic cavernous hemangioma: temporal peritumoral enhancement during multiphase dynamic MR imaging. Radiology 2000;216:692-7.
29. Bennett GL, Petersein A, Mayo-Smith WW, Hahn PF, Schima W, Saini S. Addition of gadolinium chelates to heavily T2-weighted MR imaging: limited role in differentiating hepatic hemangiomas from metastases. Am J Roentgenol 2000;174:477-85.
30. Kim T, Federle MP, Baron RL, Peterson MS, Kawamori Y. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT. Radiology 2001;219:699-706.
31. Kloppel G, Heitz PU, Capella C, Solcia E. Pathology and nomenclature of human gastrointestinal neuroendocrine (carcinoid) tumors and related lesions. World J Surg 1996;20:132-41.
32. Folberg R, Hendrix MJ, Maniotis AJ. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000;156:361-81.
33. Marcos HB, Libutti SK, Alexander HR, Lubensky IA, Bartlett DL, Walther MM, et al. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. Radiology 2002;225:751-8.